Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/14238
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan Heirstraeten, Liesbet-
dc.contributor.authorCoenen, Samuel-
dc.contributor.authorLammens, Christine-
dc.contributor.authorHENS, Niel-
dc.contributor.authorGoossens, Herman-
dc.contributor.authorMalhotra-Kumar, Surbhi-
dc.date.accessioned2012-10-05T09:13:44Z-
dc.date.available2012-10-05T09:13:44Z-
dc.date.issued2012-
dc.identifier.citationEMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518-
dc.identifier.issn1080-6040-
dc.identifier.urihttp://hdl.handle.net/1942/14238-
dc.description.abstractIn Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs.-
dc.description.sponsorshipThis study was partly funded by the Belgian Antibiotic Policy Coordination Committee.-
dc.language.isoen-
dc.publisherCENTERS DISEASE CONTROL-
dc.subject.otherImmunology; Infectious Diseases-
dc.titleAntimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium-
dc.typeJournal Contribution-
dc.identifier.epage1518-
dc.identifier.issue9-
dc.identifier.spage1515-
dc.identifier.volume18-
local.format.pages4-
local.bibliographicCitation.jcatA1-
dc.description.notesMalhotra-Kumar, S (reprint author),[Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, B-2020 Antwerp, Belgium. [Hens, Niel] Univ Hasselt, Hasselt, Belgium. surbhi.malhotra@ua.ac.be-
local.publisher.placeATLANTA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.3201/eid1809.120049-
dc.identifier.isi000307989700024-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.contributorHENS, Niel-
item.contributorVan Heirstraeten, Liesbet-
item.contributorMalhotra-Kumar, Surbhi-
item.contributorCoenen, Samuel-
item.contributorGoossens, Herman-
item.contributorLammens, Christine-
item.fullcitationVan Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; HENS, Niel; Goossens, Herman & Malhotra-Kumar, Surbhi (2012) Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium. In: EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518.-
item.validationecoom 2013-
crisitem.journal.issn1080-6040-
crisitem.journal.eissn1080-6059-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Antimicrobial drug use and macrolide-resistant streptococcus pyogenes, Belgium.pdfpublished version312.48 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

24
checked on Sep 5, 2020

WEB OF SCIENCETM
Citations

28
checked on Jun 29, 2022

Page view(s)

62
checked on Jul 3, 2022

Download(s)

96
checked on Jul 3, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.